SCHEMBL24089958

SCHEMBL24089958

CCc1ccccc1-n1c(Nc2ccccc2)nc2ccccc2c1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.58
ALDH1A1 P00352 4/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
JUN P05412 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 4/20 0.47
KDM4E B2RXH2 2/20 0.46
PDE7A Q13946 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PDE4B Q07343 1/20 0.46
RAB9A P51151 2/20 0.45
POLB P06746 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
NPC1 O15118 1/20 0.45
NTRK1 P04629 1/20 0.45
ALOX5 P09917 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24090140 0.85 ALDH1A1 (0.68) USP2ALDH1A1L3MBTL1JUNNFKB1
SCHEMBL6282118 0.85 MAPT (0.63) USP2ALDH1A1L3MBTL1LMNAMAPT
SCHEMBL24089968 0.83 USP2 (0.61) USP2ALDH1A1L3MBTL1JUNNFKB1
Etaqualone SCHEMBL30726099 0.80 ALDH1A1 (0.73) ALDH1A1L3MBTL1LMNAMAPTKDM4E
Etaqualone SCHEMBL29357362 0.80 ALDH1A1 (0.73) ALDH1A1L3MBTL1LMNAMAPTKDM4E
Etaqualone SCHEMBL30726094 0.80 ALDH1A1 (0.73) ALDH1A1L3MBTL1LMNAMAPTKDM4E
Etaqualone SCHEMBL466318 0.80 ALDH1A1 (0.73) ALDH1A1L3MBTL1LMNAMAPTKDM4E
SCHEMBL24090149 0.79 ALDH1A1 (0.67) USP2ALDH1A1L3MBTL1JUNNFKB1
SCHEMBL1129120 0.79 ALDH1A1 (0.54) ALDH1A1L3MBTL1LMNAMAPTPDE7A
SCHEMBL32666080 0.77 KDM4E (0.69) USP2ALDH1A1MAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352366-B2 2-aminoquinazolinone derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-06-07 US disclosed
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2022-05-12 US disclosed
US-20210380598-A1 2-AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220143020-A1 2-AMINOQUINAZOLINONE DERIVATIVE CNKSR1, HAX1, CRKL USP2 3443/4885ALDH1A1 645/4885L3MBTL1 4534/4885
US-20210380598-A1 2-AMINOQUINAZOLINONE DERIVATIVE CNKSR1, HAX1, SLC26A3 USP2 3548/4885ALDH1A1 739/4885L3MBTL1 4582/4885
US-11352366-B2 2-aminoquinazolinone derivative CNKSR1, HAX1, SLC26A3 USP2 3548/4885ALDH1A1 739/4885L3MBTL1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.